Replimune Group, Inc. · NASDAQ:REPL
Xynos Konstantinos sold 14,023 Replimune Group, Inc. shares (Form 4)
Traded May 18, 2026 · Filed May 20, 2026
On May 18, 2026, Xynos Konstantinos (Chief Medical Officer) sold 14,023 Replimune Group, Inc. shares at US$5.08 for US$71,237, leaving 235,662 shares. Filed May 20, 2026 (Form 4).
- Sold
- 14,023 shares
- Price
- US$5.08
- Value
- US$71,237
- Holding after
- 235,662 shares
- Trading plan
- No
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 18, 2026 | Common Stock | Sale | 14,023 | US$5.08 | 235,662 | Direct |
Source
Related
- Replimune Group, Inc.
- Xynos Konstantinos
- Replimune Group, Inc. shareholders
- Form 4 · Xynos Konstantinos · Aug 12, 2026
- Form 4 · Xynos Konstantinos · Apr 7, 2026
- Form 4 · Astley-Sparke Philip · Aug 24, 2026
- Form 4 · Hill Emily Luisa · Aug 19, 2026
- Schedule 13G/A · Ridgeback Capital Investments L.P. · Aug 14, 2026
- Form 4 · Patel Sushil · Aug 12, 2026
- Form 4 · Hill Emily Luisa · Aug 12, 2026